A clinically validated assay for rapid determination of type I and type II interferon activity in systemic inflammatory diseases

Key Points

• Type I and Type II interferon activity can be determined using a novel assay, enhancing diagnostic accuracy.
• Increased interferon activity correlates with specific systemic inflammatory diseases, providing critical insights.
• The assay employs a clinically validated method, allowing for rapid results within a clinical setting.
• Findings support the use of this assay for better management of inflammatory diseases and individualized treatment plans.